The first-ever mandatory payer prior authorization report cards just dropped under CMS-0057-F, and one number is getting all the attention: 80.7%.
That’s the Medicare Advantage appeal overturn rate for 2024. Four out of five prior authorization denials that get appealed end up reversed (KFF, 2026).
Most of the coverage has focused on what this means for providers and billing teams — how to appeal more aggressively, which payers to fight, how to build standard appeal packets. That’s useful for the provider side. But it’s not the angle that matters most to UM nurses.
Here’s the question nobody is asking on our side of the table: if 80.7% of appealed denials get overturned, what does that say about the quality of the initial determination?
And more importantly — what does it mean for prior authorization documentation for UM nurses making those decisions every day?
The Number Behind the Number
The 80.7% overturn rate is alarming on its own. But the statistic that matters more is this: only 11.5% of denied requests are ever appealed (KFF, 2026).
That means almost 9 out of 10 denials are never challenged. They stand as issued.
So the system looks like it’s working. Denial rates are tracked. Appeal rates are tracked. But the real error rate — the gap between what was initially denied and what actually should have been approved — is almost certainly much higher than what the published data shows.
For UM nurses, this creates a specific professional accountability question: when your denial doesn’t get appealed, does that mean it was correct?
Not necessarily. It means no one pushed back.
What the Payer-by-Payer Data Tells Us
The 2026 Payer PA Report Card analyzed the first wave of CMS-0057-F mandatory disclosures, and the variation at the plan level is striking.
Centene (WellCare Medicare) denies 12.3% of MA prior authorization requests — and overturns 95.5% of those on appeal. The highest overturn rate of any major insurer (KFF, 2026). That combination — high denial rate, near-100% overturn rate — is a direct signal that initial determinations are not holding up to clinical scrutiny.
UnitedHealthcare has the highest MA denial rate at 12.8% with the lowest PA volume per enrollee (1.0 per enrollee). The Senate Permanent Subcommittee on Investigations flagged UHC’s nH Predict algorithm for driving post-acute care denial rates from 8.7% in 2019 to 22.7% by 2022 — a pattern consistent with AI-assisted determinations that weren’t clinically defensible when reviewed by humans (U.S. Senate PSI, 2024).
Elevance Health (Anthem) sits at the other end with the lowest MA denial rate at 4.2% and a public commitment to not using AI to automate denials — only licensed clinicians determine that a PA does not meet criteria (Elevance Health, 2025).
Kaiser Permanente has a 51% overturn rate — the lowest of any major insurer — and a 1.6% appeal rate. Its integrated model may explain why providers rarely appeal and why initial determinations hold up more consistently.
The takeaway for prior authorization documentation for UM nurses is not which payer to work for. It’s what these overturn patterns reveal about what makes a determination defensible in the first place.
Why Denials Get Overturned: The Two Root Causes
Denials get reversed on appeal for two main reasons.
The first is clinical: the initial determination didn’t hold up to scrutiny. The criteria were applied incorrectly, the patient-specific context wasn’t weighted properly, or the level-of-care reasoning didn’t align with what the clinical picture actually showed.
The second is documentation: the clinical reasoning was sound, but it wasn’t captured clearly enough to be defensible when challenged. The note was thin. The rationale was generic. The criteria application wasn’t explicit.
Both are UM nurse problems. But the second one is entirely within your control.
This is also where AI in utilization management creates a new layer of risk. When AI tools are part of the denial workflow — and increasingly they are, whether nurses are told or not — the documentation obligation expands. If you want a structured breakdown of how to stay in control of the clinical decision when AI is involved, my post on artificial intelligence in utilization management: clinical decision support vs. clinical judgment covers exactly that. My CE course on AI in UM goes deeper with real case examples.
What Defensible Prior Authorization Documentation for UM Nurses Actually Looks Like
A denial that survives an appeal has three things in common:
1. The criteria application is explicit. It names the criteria set used (MCG, InterQual, plan-specific coverage policy), states which elements were met or not met, and connects those elements directly to the patient’s documented clinical status — not to a generic summary of the condition.
2. The patient-specific rationale is documented. Not “patient does not meet criteria for inpatient level of care.” But why, based on this patient’s specific presentation, vitals, functional status, and clinical trajectory, the requested service or level of care is not medically necessary at this time. Generic language is the fastest way to lose an appeal.
3. The documentation anticipates the appeal. Strong prior authorization documentation for UM nurses is written knowing it may be reviewed by a physician advisor, an independent reviewer, or a hearing officer months later. The clinical reasoning has to stand on its own without you in the room to explain it.
The Documentation Standard That Protects You
At minimum, your denial documentation should include:
— A patient-specific clinical summary that reflects the current presentation, not a copy-paste of the request — The criteria set or coverage policy applied, with specific elements addressed — The AI or clinical decision support output, briefly noted if applicable to your workflow — Your rationale for agreeing or disagreeing with the tool’s recommendation if AI is involved — What alternatives were communicated and what next steps were offered
If the tool suggested deny and your note is thin, you have created a paper trail that doesn’t protect you or the patient. If your note is patient-specific and explicit about reasoning, you’ve created a defensible record — regardless of what happens on appeal.
This is the core of what I cover in the Getting Started in Utilization Management CE course — medical necessity reasoning, and the real-world UM workflows that nurses aren’t taught before they land in the role.
The Medicaid Gap Is Worse Than MA
The Medicaid comparison in the 2026 data is stark and worth understanding.
Medicaid MCOs deny at 12.5% (OIG, 2023) — more than double the MA benchmark at the same period. But the appeal overturn rate drops to only 36%, compared to 80.7% in MA (OIG, 2023).
This isn’t because Medicaid determinations are more defensible. It’s largely because Medicaid patients have fewer resources to navigate the appeals process, and most states have no automatic external review pathway when a denial is upheld — unlike MA, where upheld denials automatically go to independent external review.
Only 11% of Medicaid MCO enrollees ever appeal a denial (OIG, 2023). That 89% who don’t — their denials stand.
For UM nurses working in Medicaid managed care, DSNP, or dual-eligible populations, prior authorization documentation for UM nurses carries even more weight because the safety net of appeal is less reliable. Your initial determination is often the final determination.
The New Regulatory Pressure on Initial Determinations
The 80.7% overturn rate is going to increase pressure on payers to improve the quality of initial determinations. CMS already tracks appeal overturn rates through Part C Appeals measures that feed directly into Star Ratings. Plans with consistently high overturn rates have a financial and regulatory incentive to get the initial determination right the first time.
CMS-0057-F also now requires payers to post average and median turnaround times for standard (7 calendar days) and expedited (72 hours) decisions, effective January 1, 2026. Payers must now operate faster and more accurately — which increases the operational pressure on every UM nurse in the review queue (Centers for Medicare & Medicaid Services, 2024).
That means UM nurses who document well — who can write a determination that holds up — are going to become more valuable, not less. That skill doesn’t get automated. It gets more important as AI handles volume and humans are expected to handle complexity.
For a deeper look at how UM decisions connect to cost, value-based programs, and healthcare policy, read my post on how utilization management actually controls costs. For the observation vs. inpatient documentation challenge specifically, this post on observation vs. inpatient status covers the documentation traps that cause the most preventable denials.
FAQ
What is the prior authorization overturn rate in Medicare Advantage? The industry-wide MA appeal overturn rate is 80.7% as of 2024 data — meaning four out of five appealed denials are reversed. Only 11.5% of denials are ever appealed (KFF, 2026).
Why does prior authorization documentation matter for UM nurses? Prior authorization documentation for UM nurses determines whether a denial is clinically defensible on appeal. Thin, generic documentation is the most common reason sound clinical decisions get overturned — not because the reasoning was wrong, but because it wasn’t captured.
Which payer has the highest appeal overturn rate? Centene (WellCare Medicare Advantage) has the highest appeal overturn rate at 95.5%, combined with a 12.3% MA denial rate — the strongest signal of initial determinations that are not holding up to clinical review (KFF, 2026).
Does AI in prior authorization affect UM documentation standards? Yes. When AI tools assist in denial decisions, UM nurses have an added obligation to document that human clinical judgment drove the final determination — not the tool’s output. See AI in utilization management: clinical decision support vs. clinical judgment for a full breakdown.
How is Medicaid prior authorization different from Medicare Advantage? Medicaid MCOs deny at higher rates (12.5% OIG benchmark) but have significantly lower overturn rates on appeal (36% vs. 80.7% in MA), largely because most states have no automatic external review pathway for upheld Medicaid denials (OIG, 2023).
The Bottom Line
The 80.7% overturn rate isn’t just a provider advocacy talking point. It’s a documentation quality signal that every UM nurse should be paying attention to.
Your denial doesn’t have to be wrong to get overturned. It has to be underdocumented.
Write the note that wins the appeal — even when no one files one.
Build Your UM Documentation Foundation
If you’re new to UM or building your documentation skills, the free UM Career Starter Kit includes a real concurrent review case with model documentation so you can see what this looks like in practice.
If you’re new to UM and need to understand the foundational concepts first — what UM is, how it differs from case management, how MCG and InterQual work, and what concurrent review actually looks like — start here: 👉 Getting Started in Utilization Management — 1 contact hour, BRN-approved
For AI in utilization management, clinical decision support frameworks, and automation bias: 👉 The Role of AI in Utilization Management — 3 contact hours
👉 UM Starter Bundle — best value — 4 contact hours
Accepted in 30 states. California BRN-approved, CEP #18046.
Disclaimer: Educational content only. All data referenced is publicly available. Nothing in this post reflects proprietary plan policies or employer-specific information. Always follow your organization’s policies, state and federal regulations, and contract requirements.
References
Centers for Medicare & Medicaid Services. (2024). CMS interoperability and prior authorization final rule (CMS-0057-F). https://www.cms.gov/cms-interoperability-and-prior-authorization-final-rule-cms-0057-f
Centers for Medicare & Medicaid Services. (2026, January 21). Part C and D performance data. https://www.cms.gov/medicare/health-drug-plans/part-c-d-performance-data
Elevance Health. (2025, April 14). Prior authorization. https://www.elevancehealth.com/our-approach-to-health/whole-health/prior-authorization
Harris Secure Connect. (2026, April 2). 2026 payer prior authorization report card analysis: First-ever public CMS-0057-F metrics. https://harrissecureconnect.com/2026-pa-report-card/
KFF. (2026, January 28). Medicare Advantage insurers made nearly 53 million prior authorization determinations in 2024. https://www.kff.org/medicare/issue-brief/medicare-advantage-insurers-made-nearly-53-million-prior-authorization-determinations-in-2024/
Murphy, J., Beauchamp, N., Sun, K. J., Lau, B. D., Wilson, R. F., Lobner, K., Conway, S. J., Hill, P. M., & Johnson, P. T. (2026). Adverse effects of health plan prior authorization on clinical effectiveness and patient outcomes: A systematic review. The American Journal of Medicine, 139(1), 24–32.e1. https://doi.org/10.1016/j.amjmed.2025.08.018
U.S. Department of Health and Human Services, Office of Inspector General. (2023, July). High rates of prior authorization denials by some plans and limited state oversight raise concerns about access to care in Medicaid managed care (OEI-09-19-00350). https://oig.hhs.gov/reports/all/2023/high-rates-of-prior-authorization-denials-by-some-plans-and-limited-state-oversight-raise-concerns-about-access-to-care-in-medicaid-managed-care/
U.S. Department of Health and Human Services, Office of Inspector General. (2022, April). Some Medicare Advantage organization denials of prior authorization requests raise concerns about beneficiary access to medically necessary care (OEI-09-18-00260). https://oig.hhs.gov/reports/all/2022/some-medicare-advantage-organization-denials-of-prior-authorization-requests-raise-concerns-about-beneficiary-access-to-medically-necessary-care/